Population
Patients with warfarin resistance (based on literature search 1964-1995)
Design
Review
Authors
Loading...
Clinicians must first exclude common causes of nonresponse; leaves open need for genetic registries to identify additional hereditary mechanisms.
True tissue resistance to warfarin is extremely rare; clinicians must first rule out noncompliance, drug interactions, laboratory error, and pharmacokinetic changes.
Michelle L. Hulse (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: